- This topic is empty.
Viewing 0 reply threads
-
Posts
-
-
AzurRx BioPharma has been cleared to conduct its Phase 2b OPTION 2 trial evaluating MS1819 at Therapeutics Development Network (TDN) clinical sites. Read the rest of the story here.
What do you think of this news?
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.
